rss
Thorax 2002;57:132-136 doi:10.1136/thorax.57.2.132
  • Original articles

Expiratory muscle endurance in chronic obstructive pulmonary disease

  1. A Ramírez-Sarmiento1,
  2. M Orozco-Levi1,2,
  3. E Barreiro1,
  4. R Méndez1,
  5. A Ferrer1,
  6. J Broquetas1,3,
  7. J Gea1,2
  1. 1Servei de Pneumologia and Unitat de Recerca Respiratòria I Ambiental, Hospital del Mar-IMIM, Barcelona, Spain
  2. 2CEXS, Universitat Pompeu Fabra, Barcelona, Spain
  3. 3Departamente Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
  1. Correspondence to:
    Dr J Gea, Grup de Recerca de Pneumologia, IMIM, Avda Doctor Aiguader 80, 08003 Barcelona, Spain;
    jgea{at}imim.es
  • Accepted 26 September 2001
  • Revised 3 September 2001

Abstract

Background: A reduction in expiratory muscle (ExM) endurance in patients with chronic obstructive pulmonary disease (COPD) may have clinically relevant implications. This study was carried out to evaluate ExM endurance in patients with COPD.

Methods: Twenty three patients with COPD (FEV1 35 (14)% predicted) and 14 matched controls were studied. ExM endurance was assessed using a method based on the use of an expiratory threshold valve which includes two steps. In step 1 the load is progressively increased (50 g every 2 minutes) until task failure is reached, and the pressure generated against the highest tolerated load is defined as the maximal expiratory sustainable pressure (Pthmax). In step 2 subjects breathe against a submaximal constant load (80% of Pthmax) and the time elapsed until task failure is termed the expiratory endurance time (Tth80). In addition, the strength of peripheral muscles (handgrip, HGS) and respiratory muscles (maximal inspiratory and expiratory pressures, Pimax and Pemax, respectively) was evaluated.

Results: Patients with COPD had lower ExM strength and endurance than controls: Pemax 64 (19)% predicted v 84 (14)% predicted (mean difference 20%; 95% confidence intervals (CI) 14 to 39); Pthmax 52 (27) v 151 (46) cm H2O (mean difference 99, 95% CI 74 to 123); and Tth80 9.4 (6.3) v 14.2 (7.4) min (mean difference 4.8, 95% CI 1.0 to 10.4; p<0.01 for all). Interestingly, ExM endurance directly correlated with both the severity of airways obstruction (Pthmax with FEV1, r=0.794, p<0.01) and the reduction in strength observed in different muscle groups (Pthmax with HG, Pimax or Pemax, r=0.550, p<0.05; r=0.583, p<0.001; and r=0.584, p<0.001, respectively).

Conclusions: ExM endurance is decreased in patients with COPD. This impairment is proportional to the severity of the disease and is associated with lower strength in different muscle groups. This suggests that systemic effects are implicated in the impairment observed in ExM function.

Footnotes

  • Antoni Ferrer was a Senior Researcher from the Consorci Hospitalari Parc Tauli, Sabadell. His stage of the study was funded by grant BAE-FIS (Spain).

This Article

  1. Abstract
  2. Full text
  3. PDF

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Free archive
The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.